Frequently Asked Questions
The market is segmented based on Global In Vitro Diagnostics (IVD) Market Segmentation, By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics Tissue Diagnostics, In vitro diagnostics (IVD), Others), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), End-User (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care, Others), Product and Service (Reagents, Instruments, and Software and Services) – Industry Trends and Forecast to 2031.
.
The Global In Vitro Diagnostics Ivd Market size was valued at USD 123.12 USD Billion in 2023.
The Global In Vitro Diagnostics Ivd Market is projected to grow at a CAGR of 5% during the forecast period of 2024 to 2031.
The major players operating in the market include Siemens, General Electric, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Hitachi , FUJIFILM Holdings Corporation, Carestream Health, Konica Minolta Business Solutions India Private Limited, Hologic , SouthwestMedical, TOSHIBA CORPORATION, Sanrad Medical Systems Private Limited, ONEX Corporation, Shimadzu Corporation, ESAOTE SPA .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
